NasdaqGS:LFSTHealthcare
Is LifeStance Health Group (LFST) Undervalued Following Strong Quarterly Revenue And Visit Growth?
LifeStance Health Group (LFST) attracted renewed investor interest after its latest quarter reported 26% year-over-year revenue growth and a 19% increase in visit volumes to 2.6 million, along with supportive analyst projections.
Over the past year, LifeStance Health Group’s share price return has been strong, with a 90 day gain of 59.66% and a 1 year total shareholder return of 124.64%. This suggests momentum has been building as investors reassess its growth profile and risk.
Scan beyond...